Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Недостаточность питания: нутритивная поддержка и регидратационная терапия у взрослых пациентов, нуждающихся в паллиативной медицинской помощи

Список литературы

  1. Руководство по клиническому питанию/под ред Луфта В.М.//СПб: Арт-Экспресс. 2016.- 491 с.
  2. Soeters PB, Reijven PL, van Bokhorst-de van der Schueren MA et al. A rational approach to nutritional assessment. Clin Nutr. 2008; 27: 706-16.
  3. Дисфагия Практическое руководство OMGE: J.R. Malagelada, F. Bazzoli, A. Elewaut, M. Fried, J.H. Krabshuis, G. Lindferg, P. Malfertheiner, G. Sharma, N. Vakil. 2004.- 15с.
  4. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423.
  5. Baracos VE. Pitfalls in defining and quantifying cachexia. J Cachexia Sarcopenia Muscle. 2011; 2:71–3.
  6. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8): 755–63.)
  7. Стрижак Л.Н. «Психология и педагогика»: Учебное пособие. — М. :МГИУ, 2000. — С. 259. —335с.
  8. Хоббс К., Хаас Э. Витамины для «чайников». — М.: Издательский дом «Вильямс», 2005. — С. 270. — 352 с.
  9. Первичная анорексия. Большой толковый словарь терминов по психиатрии В. А. Жмурова, Бурбелло А. Т., Шабров А. В., Денисенко П.П. Современные лекарственные средства: Клинико-фармакологический справочник практического врача. — 2-е издание, переработанное и дополненное. — СПб., М.: Издательский дом «Нева», ОЛМА-ПРЕСС Звездный мир, 2003. — С. 774. — 864 с.
  10. Radbruch L, Elsner F, Trottenberg P, Strasser F, Fearon K: European Clinical Guidelines. Clinical practice guidelines on cancer cachexia in advanced cancer patients. Aachen, Department of Palliative Medicinen/European Palliative Care Research Collaborative; 2010.Available from: http://www.epcrc.org/ [Last accessed 10th August 2014]
  11. Department of Health. Essence of Care: Benchmarks for Food & Drink, October 2010. Available from: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd Guidance/ DH_119969 [Last accessed 20th February 2013]
  12. Ersek M. Artificial Nutrition and Hydration: Clinical Issues. J Hosp Palliat Nurs 2003, 5(4): 221-230.
  13. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis and emerging treatment strategies. Annu Rev Med. 2011; 62:1–15.
  14. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., Baracos V.E. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5):489–95.
  15. Основы клинического питания. Материалы лекций для курсов Европейской ассоциации парентерального и энтерального питания / под ред. Л. Соботки: пер. с англ. – Петрозаводск: ИнтелТек, 2003. 751 с.
  16. Парентеральное и энтеральное питание/ Национальное руководство под редакцией Хабутия М.Ш., Поповой Т.С., Салтанова А.И. – М.: ГЭОТАР-Медиа, 2014. – 800 с.
  17. Рекомендации по парентеральному и энтеральному питанию для взрослых. Австрийское Общество Клинического Питания. Вена, AKE, 2003. 94 с.
  18. Stanga Z, Brunner A, Leuenberger M et al. Nutrition in clinical practice - the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr 2008; 62: 687-94.
  19. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition 2001; 17:632-7.
  20. Steiner N, Bruera E. Methods of hydration in palliative care patients. J Palliat Care. 1998; 14(2):6-13.
  21. Bruera E, Pruvost M, Schoeller T. Proctoclysis for hydration of terminally ill cancer patients. J Pain Symptom Manage. 1998; 15:216-219.
  22. Федеральный закон от 21 ноября 2011 г. N 323-ФЗ "Об основах охраны здоровья граждан в Российской Федерации" (с изменениями и дополнениями) ст. 36. Паллиативная медицинская помощь.
  23. Del Rio M.I., Shand B., Bonati P., et al. Hydration and nutrition at the end of life: a systematic review of emotional impact, perceptions, and decision-making among patients, family, and health care staff. Psycho Oncology. 2012; 21(9): 913-21.
  24. Fabbro ED, Shalini D, Bruera E. Symptom Control in Palliative Care – Part II: Cachexia/Anorexia and Fatigue. J Palliat Med 2006; 9(2): 409-421.
  25. Alix E, Berrut G, Boreґ M, Bouthier-Quintard F, Buia JM, Chlala A, et al. Energy requirements in hospitalized elderly people. JAGS 2007; 55: 1085–9.
  26. Нутритивная недостаточность и методы ее лечения у онкологических больных / А.В. Снеговой, А.И. Салтанов, Л.В. Манзюк, В.Ю. Сельчук // Практическая онкология. – 2009. – № 1. – С. 49–57.
  27. Принципы питания больных, оперированных по поводу рака желудка / А.Л. Хомичук, В.И. Пилипенко, А.К. Шаховская // Consilium medicum. – 2014. – Т. 16. – № 8.– С. 89–92.
  28. Ockenga J., Valentini I. Review article: anorexia and cachexia in gastrointestinal cancer // Aliment Pharmacol Ther. – 2005. — № 22. – P. 583–94.
  29. Jensen GL. Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. JPEN 2006; 30: 453-63.
  30. Terrier N, Senecal L, Dupuy AM et al. Association between novel indices of malnutrition- inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int 2005; 9: 159-168.
  31. Thomas DR. Loss of skeletal muscle mass in aging; examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007; 26: 389-399.
  32. Контроль симптомов в паллиативной медицине: руководство / под ред. Г.А. Новикова – М.: ГЭОТАР-Медиа, 2015. – 248 с.
  33. Ryan M, Salle A, Favreau AM, Simard G, Dumas JF, Malthiery Y, Berrut G, Ritz P. Oral supplements differing in fat and carbohydrate content: effect on the appetite and food intake of undernourished elderly patients. Clin Nutr 2004; 23(4): 683-689.
  34. Morley JE. Cancer and cachexia. Cur Opin Clin Nutr Metab Care 2009; 12(6): 607-610.
  35. National Institute for Health and Clinical Excellence. Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition, February 2006. Available from: http://www.nice.org.uk/CG32 [Last accessed 20th February 2013].
  36. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut 2003; 52(SuppVII): vii1-vii12.
  37. Kondrup J, Rasmussen H, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on analysis ofcontrolled clinical trials. Clinical Nutrition 2003; 22: 321-36.
  38. Elia M. The MUST report. Nutritional screening of adults: a multidisciplinary responsibility. Red-ditch: BAPEN 2003.
  39. Ferguson M, Capra S, Bauer J, Banks M. Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition 1999; 15: 458-64.)
  40. Caccialanza R, Cereda E, Klersy C, et al. Phase angle and handgrip strength are sensitive early markers of energy intake in hypophagic, non-surgical patients at nutritional risk, with contraindications to enteral nutrition. Nutrients. 2015; 7:1828-40.
  41. Grundmann O, Yoon SL, Williams JJ. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients-a comprehensive review. Eur J Clin Nutr. 2015. [Epub ahead of print]. doi:10.1038/ejcn.2015.126.
  42. Valentini V, Marazzi F, Bossola M, et al. Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy. J Hum Nutr Diet. 2012; 25:201-8.
  43. Ravasco P, Monteiro-Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr. 2012; 96: 1346-53.
  44. Hubbard GP, Elia M, Holdoway A, et al. A systematic review of compliance to oral nutritional supplements. Clin Nutr. 2012; 31:293-312.
  45. Frenkel M, Abrams DI, Ladas EJ, et al. Integrating dietary supplements into cancer care. Integr Cancer Ther. 2013; 12:369-84.
  46. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective expert report. Washington, DC: AICR. 1997 and update 2007.
  47. British Geriatrics Society: Nutritional Advice in Common Clinical Situations, revised August 2009. Available from: http://www.bgs.org.uk/index.php?option=com_content&view=article&id=41:gpgnutrition&catid =12:goodpractice&Itemid=106 [Last accessed 20th February 2013].
  48. Harle L, Brown T, Laheru D, Dobs A. Omega-3 Fatty Acids for the Treatment of Cancer Cachexia: Issues in designing Clinical trials of Dietary Supplements. J Altern Complement Med 2005; 11(6): 1039-1046.
  49. Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 2009; 17: 83-90.
  50. Fearon КС. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008; 44: 1124-32.
  51. Watson et al, Nutrition and Hydration in End of Life Care 2009, p.765
  52. Thomas B & Bishop J. Manual of Dietetic Practice (fourth edition). Blackwell Publishing Ltd, 2007.
  53. NHS National Patient Safety Agency. Protected Mealtimes Review: Findings and Recommendations Report, January 2007. Available from: http://www.nrls.npsa.nhs.uk/resources/?entryid45=59806 [Last accessed 20th February 2013].
  54. Российские клинические рекомендации по проведению нутритивной поддержки у больных с острыми нарушениями мозгового кровообращения А.М.Алашеев, А.А.Белкин, Г.Е.Иванова, И.Н. Лейдерман, В.М Луфт, С.С. Петриков, Л.В.Стаховская, А.Ю. Суворов, Д.Р.Хасанова, Н.А. Шамалов.
  55. Scott A. Acting on screening results: a guide to treating malnutrition in the community. Br J Community Nurs 2008; 13: 450-56.
  56. Nieuwenhuizen WF, Weenen H, Rigby P, Hetherington MM. Older adults and patients in need of nutritional support: Review o fcurrent treatment options and factors influencing nutritional intake. Clin. Nutr. 2010; 29: 160-9.
  57. Schindler A, Denaro N, Russi EG, Pizzorni N, Bossi P, Merlotti A, et al. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol 2015; 96: 372-84.
  58. Stratton RJ, Green CJ, Elia M, Ed. Disease-related malnutrition: an evidence-based approach to treatment. Oxon (UK), CAB International, 2003.
  59. Löser Chr, Aschl G, Hébuterne X, et al. ESPEN guidelines on artificial enteral nutrition/ Percutaneous endoscopic gastrostomy (PEG). Clin Nutr 2005; 24: 848-861.
  60. Sampson EL, Candy В and Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database of Systematic Reviews 2009; 2: Art. No. CD007209. DOI: 10.1002/14651858.CD007209.pub2.
  61. Lanuke K, Fainsinger RL and de Demoissac D. Hydration management at the end of life. Journal of Palliative Medicine 2004; 7(2): 257-63.
  62. Briggs S and Vernon MJ. Decisions on life sustaining therapy: nutrition and fluids in medical ethics and the elderly, third edition. Rai G (ed.). Abingdon: Radcliffe Publishing, 2009.
  63. Delmore G. Should cancer patients with incurable disease receive parenteral or enteral nutritional support? European Journal of Cancer 1998; 34(3): 282-4.
  64. Basics in clinical nutrition: nutritional support in different clinical situations. Sobotka L. ЕSPEN, the European e-Journal of Clinical Nutrition and Metabolism. (2004, accessed May 2010: e226-8.
  65. Bruera E, et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. JCO 2005; 23(1): 2366-71.
  66. Bozzetti F. Is enteral nutrition a primary therapy in cancer patients? Gut 1994; 35(suppl): S65-8.
  67. Fainsinger R. Nonoral hydration in palliative care. Journal of Palliative Medicine 2006; 9(1): 206-8.
  68. Tchekmedian NS, Zahyna D, Halpert C, et al. Assessment and maintenance of nutrition in older cancer patients. Oncology 1992; 49(suppl 2): 105-11.
  69. Cynober L. Basics in clinical nutrition: some laboratory measures of response to nutrition in research and clinical studies. ЕSPEN, the European e-Journal of Clinical Nutrition and Metabolism 2009; 4: e226-8.
  70. Plauth M, Cabre E, Riggio О et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006; 25: 285-294.
  71. Rousseau P. Management of symptoms in the actively dying patient. In: Principles and Practice of Palliative Care and Supportive Oncology. Berger AM, Portenoy RK, and Weissman DE, eds. 2nd Edition. Philadelphia, PA: Lippincott, Williams, & Wilkins; 2002).
  72. Van der Reit P, et al. Palliative care professionals perceptions of nutrition and hydration at the end of life. Jnt J Pall Nurs 2008; 14(3): 145-51.

  1. Magne N, et al. Comparison of nasogastric tube and percutaneous fluoroscopic gastrostomy in advanced H&N cancer patients. Eur Arch Oto-Rhino-Laryngo 2001; 258(2): 89- 92.
  2. Kwok T, et al. Appendix - information given to participants on clinical outcomes of CPR and tube feeding. JAN 2007; 3: 262.
  3. Winter SM. Terminal nutrition: framing the debate for the withdrawal of nutritional support in terminally ill patients. Am J Med 2000; 109: 723-6.
  4. McAtear CA, ed. Current perspectives on enteral nutrition in adults. Maidenhead: BAPEN 1999.
  5. Anderton A, ed. Microbial contamination of enteral feeds - what are the risks? Trowbridge: Nutricia Limited 2000.
  6. Payne-James J, Grimble G, Silk D, eds. Artificial nutritional support in clinical practice. London: Edward Arnold 1995.
  7. Rombeau JL, Roladelli RH, eds. Enteral and tube feeding (third edition). Philadelphia: WB Saunders 1997.
  8. Loeb MB, Becker M, Eady A, Walker-Dilks C. Aspiration pneumonia prevention interventions in the elderly: a systematic review. J Am Geriatr Soc. 2003; 51(7):1018-1022.
  9. Meier DE, Ahronheim JC, Morris J, Baskin-Lyons S, Morrison RS. High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding. Arch Intern Med. 2001; 161(4):594-599.
  10. Finucane T, Christmas C, Travis K. Tube feeding in patients with advanced dementia.1999; 282:1365-1369.
  11. Finucane T, Bynum J. Use of a feeding tube to prevent aspiration pneumonia. Lancet.1996; 348:1421-1424.
  12. Croghan J, Burke E, Caplan S, Denman S. Pilot study of 12-month outcomes of nursing home patients with aspiration on videofluoroscopy. Dysphagia. 1994; 9:141-146.
  13. Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted nutrition for palliative care in adult patients. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006274. DOI: 10.1002/14651858.CD006274.pub2.
  14. Bavin L. Artificial rehydration in the last days of life: is it beneficial? International Journal of Palliative Nursing 2007; 13(9): 445-9.
  15. Dalai S and Bruera E. Dehydration in cancer patients: to treat or not to treat. Journal of Support Oncology 2004; 2: 467-87.
  16. Morita T, Shima Y, Mitsunori M, Kimura R and Adachi I. Physician- and nurse-reported effects of intravenous hydration therapy on symptoms of terminally ill patients with cancer. Journal of Palliative Medicine 2004; 7(5): 683-93.

  1. Guan X-L, Wang H, Huang H-S, Meng L. Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 2015 May 3;36(5):671e81, Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar J-L, BonnefontRousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008 Mar 25;70(13):1004e9, De Pauw A, Dejaeger E, D’hooghe B, Carton H. Dysphagia in multiple sclerosis. Clin Neurol Neurosurg 2002 Sep; 104(4): 345e51.
  2. Rosa Burgosa, Irene Breton , Emanuele Cereda, Jean Claude Desport, Rainer Dziewas, Laurence Genton, Filomena Gomes, Pierre Jesus, Andreas Leischker, Maurizio Muscaritoli, Kalliopi-Anna Poulia, Jean Charles Preiser, Marjolein Van der Marck, Rainer Wirth, Pierre Singer, Stephan C. Bischoff Clinical Nutrition 37 (2018) 354e396 ESPEN guideline clinical nutrition in neurology
  3. Stratton RJ, Green CJ, Elia M, Ed. Disease-related malnutrition: an evidence-based approach to treatment. Oxon (UK), CAB International, 2003,
  4. Перкутанная рентгенассистированная гастростомия у больных с опухолевой дисфагией, Л.В. Цепеншиков, Р.И. Абсалямов, М.В. Неклюдова, В.К. Лядов Журнал Онкология им. П.А. Герцена. 4, 2015
  5. Cristian D, Poalelungi A, Anghel A, Burcos¸ T, Grigore R, Bertes¸ teanu S, et al. Prophylactic percutaneous endoscopic gastrostomy (PEG) - the importance of nutritonal support in patients with head and neck cancers (HNCs) or neurogenic dysphagia (ND). Chir (Bucur) 2015; 110(2): 129-36.
  6. Gencosmanoglu R. Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions. Neurocrit Care 2004;1(3): 309- 317.
  7. Справочник по клиническому питанию / под ред. Луфта В.М. /СПб: «Росбалт». 2018. 362с.
  8. Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017 Oct;36(5):1187-1196
  9. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48
  10. August DA, Huhmann MB; American Society for Parenteral and Enteral Nutrition (ASPEN) Board of Directors. ASPEN clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN. 2009; 33:472-500.
  11. French Speaking Society of Clinical Nutrition and Metabolism (SFNEP). Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): Summary of recommendations for adults undergoing non-surgical anticancer treatment. Dig Liver Dis. 2014 46:667-74.

  1. «Роль энтерального и парентерального питания при трансплантации гемопоэтических стволовых клеток у взрослых и подростков»: Автореф. дисс. кмн // Кучер М.А. – 2011. – 22 с.
  2. Chalela JA, Lopez JI. Medical management of hunger strikers. Nutr Clin Pract. 2013; 28:128–135. [PubMed: 23090653]
  3. Coletti C, Paolini M, Scavone L, Felice MR, Laviano A, Rossi Fanelli F, et al. Predicting the outcome of artificial nutrition by clinical and functional indices. Nutrition 2009;25:11–9.
  4. Fan CG, Ren JA, Wang XB, Li JS. Refeeding syndrome in patients with gastrointestinal fistula. Nutrition 2004; 20: 346-50.
  5. Kagansky N, Levy S, Koren-Morag N et al. Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival. J Intern Med 2005; 257: 461-8.
  6. Gonzalez Avila G, Fajardo Rodriguez A, Gonzalez Figueroa E. The incidence of the refeeding syndrome in cancer patients who receive artificial nutritional treatment. Nutr FIosp 1996; 11: 98-101.
  7. Ornstein RM, Golden NH, Jacobson MS, Shenker IR. Hypophosphatemia during nutritional rehabilitation in anorexia nervosa: implications for refeeding and monitoring. J Adolesc Health 2003; 32: 83-8.
  8. Hernandez-Aranda IC, Gallo-Chico B, Luna-Cruz ML et al. Malnutrition and total parenteral nutrition: a cohort study to determine the incidence of refeeding syndrome Rev Gastroenterol Mex 1997; 62: 260-5.
  9. Marinella MA. The refeeding syndrome and hypophosphatemia. Nutr Rev 2003; 61: 320- 3.
  10. Hearing SD. Refeeding syndrome. BMJ 2004; 328: 908-9.
  11. Kraft MD, Btaiche IF, Sacks GS. Review of the refeeding syndrome. Nutr Clin Pract 2005; 20: 625-33.
  12. Crook MA, Panteli JV. The refeeding syndrome and hypophosphataemia in the elderly. J Intern Med 2005; 257: 397-8.
  13. Afzal NA, Addai S, Fagbemi A et al. Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr 2002; 21: 515-20.
  14. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ 2003; 326:30-4.
  15. Raijmakers NJ, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G, et al. Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol 2011; 22: 1478-86.
  16. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994:272: 1263-6.
  17. Kang JH, Shin SH, Bruera E. Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 2013;39(1):105—12.
  18. Prevost V, Grach MC. Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care 2012; 21: 581—90.
  19. Dasgupta M, Binns MA, Rochon PA. Subcutaneous fluid infusion in a long-term care setting. J Am Geriatr Soc 2000; 48: 795–9.
  20. Remington R, Hultman T. Hypodermoclysis to treat dehydration: a review of the evidence. J Am Geriatr Soc 2007; 55: 2051–5.
  21. O'Keeffe ST, Lavan JN. Subcutaneous fluids in elderly hospital patients with cognitive impairment. Gerontology. 1996; 42(1): 36-39.
  22. Berger EY. Nutrition by hypodermoclysis. J Am Geriatr Soc. 1984; 32(3):199-203.
  23. Slesak G, Schnurle JW, Kinzel E, Jakob J, Dietz PK. Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial. J Am Geriatr Soc. 2003; 51(2):155-160.
  24. Mercadante S, Ferrera P, Girelli D, Casuccio A. Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage. 2005; 30(4):354-358.
  25. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004; 2(6):467-479, 483.
  26. Macmillan K, Bruera E, Kuehn N, Selmser P, Macmillan A. A prospective comparison study between a butterfly needle and a Teflon cannula for subcutaneous narcotic administration. J Pain Symptom Manage. 1994; 9(2):82-84.
  27. Barua P, Bhowmick BK. Hypodermoclysisda victim of historical prejudice. Age Ageing 2005;34:215–7.
  28. Frisoli Junior A, de Paula AP, Feldman D, Nasri F. Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients. Drugs Aging 2000; 16: 313–9.
  29. Rochon PA, Gill SS, Litner J, Fischbach M, Goodison AJ, Gordon M. A systematic review of the evidence for hypodermoclysis to treat dehydration in older people. J Gerontol A Biol Sci Med Sci 1997; 52: M169–76.
  30. Turner T, Cassano AM. Subcutaneous dextrose for rehydration of elderly patientsdan evidence-based review. BMC Geriatr 2004; 4:2.
  31. Jain S, Mansfield B, Wilcox MH. Subcutaneous fluid administrationdbetter than the intravenous approach? J Hosp Infect 1999; 41: 269–72.
  32. Slesak G, Schnurle JW, Kinzel E, Jakob J, Dietz PK. Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial. J Am Geriatr Soc. 2003; 51(2):155-160.
  33. Bruera E, Pruvost M, Schoeller T. Proctoclysis for hydration of terminally ill cancer patients. J Pain Symptom Manage. 1998; 15:216-219.
  34. Lanuke K, Fainsinger RL, de Moissac D. Hydration management at the end-of- life. J Palliat Med. 2004; 7(2):257-263.
  35. Jann Arends, Patrick Bachmann , Vickie Baracos , Nicole Barthelemy , Hartmut Bertz , Federico Bozzetti , Ken Fearon , Elisabeth Hutterer , Elizabeth Isenring , Stein Kaasa , Zeljko Krznaric , Barry Laird , Maria Larsson , Alessandro Laviano , Stefan Miihlebach, Maurizio Muscaritoli , Line Oldervoll, Paula Ravasco, Tora Solheim , Florian Strasser, Marian de van der Schueren, Jean-Charles Preiser Рекомендации ESPEN по питанию пациентов с онкопатологией Европейское общество клинического питания и метаболизма. . «Clinical Nutrition» 36 (2017) 11-48.
  36. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, et al. Randomized Comparison of Megestrol Acetate Versus Dexamethasone Versus Fluoxymestrone for the Treatment of Cancer Anorexia/Cachexia. J Clin Oncol 1999; 17(10): 3299-3306.
  37. Miller S, McNutt L, McCann MA, McCorry N. Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat Med 2014; 17: 482-5.
  38. Moertel CG, Schutt AJ, Reitemeier RJ, Hanh RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974; 33: 1607-9.
  39. Государственный реестр лекарственных средств МЗ РФ. https://grls.rosminzdrav.ru/ Официальная инструкция к препарату Мегэстрол
  40. Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol 2005;23:8500-11.
  41. Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 2001; 12: 289-300.
  42. Lesniak W, Bala M, Jaeschke R, Krzakowski M. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome—a systematic review and meta-analysis. Pol Arch Med Wewntrznej 2008; 118: 636-44.
  43. Ruiz Garcia V, Lopez-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2013; 28(3).
  44. Del Fabbro E, Hui D, Dalai S, Dev R, Nooruddin ZI, Bruera E. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med 2011; 14: 1004-8.
  45. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. J Gastroenterol Hepatol 2009; 24: 537- 46.
  46. Bruera ED, MacEachern TJ, Spachynski KA, LeGatt DF, MacDonald RN, Babul N, et al. Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metodopramide for the management of chronic nausea in patients with advanced cancer. Cancer 1994:74: 3204-11.
  47. Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind, crossover study of controlled-release metodopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 2000; 19: 427-35.
  48. Cadario BJ, Leathern AM, editors. Drug information reference. 5th ed. Vancouver: BC Drug and Poison Information Centre; 2003. p. 462—3.
  49. Moses AW, Slater C, Preston T, Barber MD, Fearon КС. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with N-3 fatty acids. Br J Cancer 2004; 90: 996-1002.
  50. Van der Meij BS, Langius JA, Smit EF, Spreeuwenberg MD, von Blomberg BM, Heijboer AC, et al. Oral nutritional supplements containing (N-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment J Nutr 2010; 140: 1774-80; 66:399-404.
  51. Silva J, de A, Trindade EB, Fabre ME, Menegotto VM, Gevaerd S, Buss Zda S, et al. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 2012; 64: 267-73.
  52. Mocellin MC, Camargo CQ, Nunes EA, Fiates GM, Trindade EB. A systematic review and meta-analysis of the N-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin Nutr 2016;35:359-69.
  53. Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, et al. Effect of N-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr 2012; 108: 327-33.
  54. Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 2011; 117: 1775- 82; 3774—80.
  55. Trabal J, Leyes P, Forga M, Maurel J. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 2010; 25: 736-40.
  56. Sanchez-Lara K, Turcott JG, Juarez-Hernandez E, Nunez-Valencia C, Villanueva G, Guevara P, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr 2014; 33: 1017-23.
  57. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998; 82: 395-402.
  58. Colomer R, Moreno-Nogueira JM, Garda-Luna PP, Garcia-Peris P, Garcia-de-Lorenzo A, Zarazaga A, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007; 97: 823-31.
  59. Eltweri AM, Thomas AL, Chung WY et al. The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial. Anticancer Res. 2019 Feb;39(2):853-861.
  60. Инструкция по медицинскому применению https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=446e3809-41eb-49b5-bede- 9e3df9581d4d&t=
  61. Снеговой А.В., Кононенко И.Б., Ларионова В.Б., Салтанов А.И., Сельчук В.Ю. Синдром анорексии-кахексии у онкологических больных. Клиническая онкогематология 2015; 8(2): 185–190.
  62. Berger MM, Reintam-Blaser A, Calder PC et al. Monitoring nutrition in the ICU. lin Nutr. 2019 Apr;38(2):584-593
  63. Michael Shaw, Jeremy Woodward, Sarah Galbraith Which palliative care patients are most likely to benefit from parenteral nutrition? A retrospective service evaluation Clin Med (Lond). 2016 Jun 1; 16(Suppl 3): s16.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*